Inhibrx
INBX
INBX
101 hedge funds and large institutions have $172M invested in Inhibrx in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 11 closing their positions.
Holders
101
Holders Change
+5
Holders Change %
+5.21%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
17
Increased
31
Reduced
29
Closed
11
Calls
$1.28M
Puts
$418K
Net Calls
+$860K
Net Calls Change
-$1.42M
Top Buyers
| 1 |
S
1
Sanofi
Paris,
France
|
$17.8M |
| 2 |
2
HighTower Advisors
Chicago,
Illinois
|
$12M |
| 3 |
CP
3
Castalian Partners
Excelsior,
Minnesota
|
$2.95M |
| 4 |
4
BlackRock
New York
|
$12.8M |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$2.21M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$612K |
| 2 |
CL
2
CSS LLC
Chicago,
Illinois
|
$796K |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$825K |
| 4 |
4
Millennium Management
New York
|
$3.98M |
| 5 |
5
Russell Investments Group
London,
United Kingdom
|
$837K |
